Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Literature
1.
Martin-Loeches I, Lisboa T, Rodriguez A, Putensen C, Annane D, Garnacho-Montero J, Restrepo MI, Rello J (2010) Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 36:612–620. doi:10.​1007/​s00134-009-1730-y CrossRefPubMed
2.
American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRef
3.
Low DE (2004) Quinolone resistance among pneumococci: therapeutic and diagnostic implications. Clin Infect Dis 38(Suppl 4):S357–S362CrossRefPubMed
4.
Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72CrossRefPubMed
5.
Waterer GW (2010) Are macrolides now obligatory in severe community-acquired pneumonia? Intensive Care Med 36:562–564CrossRefPubMed
Metadata
Title
Questions remain regarding mandatory use of macrolides in community-acquired pneumonia
Authors
Benjamin P. Westley
Philip A. Chan
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 10/2010
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-010-1950-1

Other articles of this Issue 10/2010

Intensive Care Medicine 10/2010 Go to the issue

Original

Intensive care reimbursement practices: results from the ICUFUND survey

Correspondence

SDD: don’t be selective in considering pros and cons

Correspondence

Macrolide combination antibiotic therapy should be prudently considered in complicated CAP cases and in regions with low macrolide susceptibility

Review

A critical appraisal of the quality of critical care pharmacotherapy clinical practice guidelines and their strength of recommendations

Correspondence

Reply to Westley and Chan and to Shih et al.

Correspondence

Intravenous colistimethate administration and colistin lung tissue concentrations